Spagnoli Family Cancer Center
BreastGastrointestinal (colon, rectum, pancreas)Genitourinary (bladder, kidney, prostate)LeukemiaLymphomaMelanomaMultiple MyelomaFrequently Asked Questions
Orange Regional Medical Center
707 East Main Street
Middletown, NY 10940
Clinical trials provide patients at all stages of cancer with leading edge medical treatment and the highest level of care. In most cases, the new treatment has already shown promise of being an improvement over the standard treatment. Many clinical trials are tests to see how much better a new treatment works than the current one.
Orange Regional Medical Center currently offers 22 clinical trial protocols for the following types of cancer:
Under FDA regulations, an Institutional Review Board (IRB) is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. The IRB reviews and has authority to approve, require modifications in (to secure approval), or disapprove all research activities. This group review serves an important role in the protection of the rights and welfare of human research subjects. All protocols must be approved by the IRB prior to enrolling any study patients. Orange Regional Medical Center's IRB is made up of an equal amount of hospital employees and community members.
Anyone interested in learning more about our clinical trials or the IRB may contact our research coordinator: Jessica Gerlach, CCRP (Certified Clinical Research Professional) at 845-333-1133 or firstname.lastname@example.org.
For more information on clinical trials, please visit